Empiric Antibiotic Recommendation
For this patient with both a deep toe web infection from pedicure trauma and a suspected dental infection, start amoxicillin-clavulanate (augmentin) 875 mg twice daily, as this single agent provides optimal coverage for both polymicrobial odontogenic infections and gram-negative/gram-positive toe web pathogens.
Rationale for Single-Agent Coverage
This recommendation is based on converging evidence from multiple high-quality guidelines and recent research:
Odontogenic Infection Coverage
The 2024 WHO guideline 1 and 2014 IDSA guideline 2 both recommend amoxicillin-clavulanate as first-line therapy for odontogenic infections. Recent 2026 research 3 confirms that aminopenicillins with beta-lactamase inhibitors remain highly effective with only 6.9% resistance rates in odontogenic infections 4, making them superior to alternatives like clindamycin which shows 38.9% resistance 4.
The polymicrobial nature of dental infections (involving streptococci, anaerobes, and occasionally Staphylococcus) is well-covered by amoxicillin-clavulanate 5, 6.
Toe Web Infection Coverage
The 2026 German guideline on infected interdigital intertrigo 7 describes these as polymicrobial infections involving gram-negative bacteria (Pseudomonas aeruginosa, Enterobacterales), gram-positive pathogens (S. aureus, streptococci), and fungi. While historical data 8, 9 emphasized Pseudomonas, the updated guideline 7 clarifies that soft tissue extension in immunocompetent patients is typically caused by S. aureus, not gram-negatives.
Amoxicillin-clavulanate provides:
- Gram-positive coverage (S. aureus, streptococci) for potential cellulitis extension
- Reasonable gram-negative coverage for many Enterobacterales
- Anaerobic coverage from the clavulanate component
Important Caveats and Clinical Pearls
When This Regimen May Fail
If the toe infection shows signs of true soft tissue infection (cellulitis/phlegmon) with systemic symptoms, the IDSA guideline 2 recommends broader coverage. For severe infections with SIRS or immunocompromise, consider vancomycin plus piperacillin-tazobactam 2.
If Pseudomonas is strongly suspected (green exudate, prior cultures, healthcare exposure), amoxicillin-clavulanate has poor Pseudomonas coverage. Consider adding or switching to a fluoroquinolone (ciprofloxacin) or using piperacillin-tazobactam 1.
Penicillin Allergy Considerations
If the patient reports penicillin allergy:
- Do NOT reflexively use clindamycin - it has 38.9% resistance in dental infections 4 and is associated with higher adverse effects 3
- Recent evidence 3 supports using PEN-FAST scoring and allergy de-labeling strategies
- For non-confirmed allergies, cefazolin may be safe 3
- For confirmed severe allergies: moxifloxacin (covers both sites well) 5 or combination therapy with a fluoroquinolone plus metronidazole 1
Source Control is Mandatory
Antibiotics alone are insufficient 7. The toe infection requires:
- Local wound care with antiseptics
- Debridement of macerated tissue
- Edema reduction and elevation 2
- Treatment of interdigital fungal infection if present 2, 7
The dental infection requires:
- Drainage if abscess present
- Definitive dental treatment (extraction/root canal)
- Antibiotics are adjunctive only 6
Duration and Monitoring
- Standard duration: 5-7 days 2, 6
- Extend if not improving within this timeframe 2
- Hospitalization criteria: SIRS, altered mental status, hemodynamic instability, concern for necrotizing infection, or failed outpatient therapy 2
- The 2025 study 4 found that moxifloxacin resistance (though rare at 4.5%) was associated with 10-fold increased risk of systemic complications, emphasizing the importance of early reassessment if not improving
Red Flags Requiring Immediate Escalation
- Rapidly spreading erythema or crepitus (necrotizing infection)
- Fever, tachycardia, hypotension (SIRS/sepsis)
- Diabetes, immunosuppression, or peripheral vascular disease (higher complication risk) 7
- Facial swelling from dental infection threatening airway
In these scenarios, immediate surgical consultation and IV broad-spectrum antibiotics (vancomycin plus piperacillin-tazobactam or carbapenem) are indicated 2, 1.